|Articles|May 4, 2021
Optimized Biopharmaceutical Analysis: Automated MS Data Workflow for Targeted, Site-Specific N-Glycosylation Monitoring
Author(s)Genedata
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
